Prednisone plus a calcineurin inhibitor are considered standard treatment for chronic graft-versus-host disease, but the best regimen for salvage treatment is not clear

Author： Adis International Limited  

Publisher： Adis International

ISSN： 1172-0360

Source： Drugs & Therapy Perspectives, Vol.23, Iss.2, 2007-02, pp. : 7-10

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Novel approaches to the treatment of chronic graft-versus-host disease

By Gaziev D.   Lucarelli G.  

Expert Opinion on Investigational Drugs, Vol. 10, Iss. 5, 2001-05 ,pp. : 909-923

Informa Healthcare

Access to resources Recommend Favorite

Novel therapeutics for the treatment of graft-versus-host disease

By Jacobsohn David A  

Expert Opinion on Investigational Drugs, Vol. 11, Iss. 9, 2002-09 ,pp. : 1271-1280

Informa Healthcare

Access to resources Recommend Favorite

Chronic Graft-Versus-Host Disease

By  

Current Pharmaceutical Design, Vol. 14, Iss. 20, 2008-07 ,pp. : 1974-1986

Bentham Science Publishers

Access to resources Recommend Favorite

Immunomodulation and pharmacological strategies in the treatment of graft-versus-host disease

By Li Minghui   Sun Kai   Welniak Lisbeth A   Murphy William J  

Expert Opinion on Pharmacotherapy, Vol. 9, Iss. 13, 2008-09 ,pp. : 2305-2316

Informa Healthcare

Access to resources Recommend Favorite

The Role of Oral Beclometasone Dipropionate in the Treatment of Gastrointestinal Graft-versus-Host Disease

By Doan Phuong L.   Chao Nelson J.  

Drugs, Vol. 69, Iss. 10, 2009-07 ,pp. : 1339-1350

Adis International

Access to resources Recommend Favorite